Invention Grant
- Patent Title: Agents, uses and methods for the treatment of synucleinopathy
-
Application No.: US17004447Application Date: 2020-08-27
-
Publication No.: US11421024B2Publication Date: 2022-08-23
- Inventor: Pekka Kallunki , Karina Fog , Louise Buur Vesterager , Ann-Louise Bergstrôm , Florence Sotty , David Satijn , Edward Van Den Brink , Paul Parren , Rik Rademaker , Tom Vink , Ibrahim John Malik , Liliana Christina Pereira Montezinho
- Applicant: H. Lundbeck A/S
- Applicant Address: DK Valby
- Assignee: H. Lundbeck A/S
- Current Assignee: H. Lundbeck A/S
- Current Assignee Address: DK Valby
- Agency: Nelson Mullins Riley & Scarborough LLP
- Agent Jane E. Remillard, Esq.; Christopher L. Frank
- Priority: GB1512203 20150713
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K51/00 ; A61K39/395 ; A61P25/16 ; A61P25/28 ; G01N33/68 ; A61K39/00
Abstract:
The invention relates to novel monoclonal anti-alpha-synuclein antibodies. The antibodies can be used for treating a synucleinopathy such as Parkinson's disease (including idiopathic and inherited forms of Parkinson's disease), Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease (LBV), Combined Alzheimer's and Parkinson disease, pure autonomic failure and multiple system atrophy.
Public/Granted literature
- US20210147522A1 AGENTS, USES AND METHODS FOR THE TREATMENT OF SYNUCLEINOPATHY Public/Granted day:2021-05-20
Information query
